Duff, Audrey F. http://orcid.org/0000-0002-4825-2915
Jurcisek, Joseph A.
Kurbatfinski, Nikola
Chiang, Tendy
Goodman, Steven D.
Bakaletz, Lauren O. http://orcid.org/0000-0002-0017-1710
Bailey, Michael T. http://orcid.org/0000-0002-2222-3980
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Deafness and Other Communication Disorders (R01 DC003915)
Article History
Received: 24 July 2023
Accepted: 22 January 2024
First Online: 3 February 2024
Competing interests
: L.O.B. is an inventor of technology related to PilA-derived immunogens that is licensed to GlaxoSmithKline Biologicals. L.O.B. and S.D.G. are inventors of technology related to the DNABII-directed approach, rights to which have been licensed to Clarametyx Biosciences, Inc. The remaining authors declare no competing interests.